vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $270.8M, roughly 1.3× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -6.6%, a 7.4% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs -16.5%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
HCM vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $339.5M |
| Net Profit | $2.0M | $-22.6M |
| Gross Margin | 37.7% | 11.5% |
| Operating Margin | -13.2% | -2.6% |
| Net Margin | 0.7% | -6.6% |
| Revenue YoY | -16.5% | 48.3% |
| Net Profit YoY | -83.6% | 8.3% |
| EPS (diluted) | $0.00 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $339.5M | ||
| Q3 25 | — | $354.8M | ||
| Q2 25 | $277.7M | $280.9M | ||
| Q1 25 | $324.5M | $213.8M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | — | $220.9M | ||
| Q2 24 | $305.7M | $208.4M | ||
| Q1 24 | — | $192.5M |
| Q4 25 | $2.0M | $-22.6M | ||
| Q3 25 | — | $-19.1M | ||
| Q2 25 | $455.0M | $-21.6M | ||
| Q1 25 | $11.9M | $-27.2M | ||
| Q4 24 | — | $-24.6M | ||
| Q3 24 | — | $-14.3M | ||
| Q2 24 | $25.8M | $-17.8M | ||
| Q1 24 | — | $-23.7M |
| Q4 25 | 37.7% | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | 0.1% | 14.7% | ||
| Q1 25 | 48.0% | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | 41.1% | 19.9% | ||
| Q1 24 | — | 19.4% |
| Q4 25 | -13.2% | -2.6% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | -1.3% | -5.3% | ||
| Q1 25 | -5.0% | -6.1% | ||
| Q4 24 | — | -4.3% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | -9.0% | -7.9% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | 0.7% | -6.6% | ||
| Q3 25 | — | -5.4% | ||
| Q2 25 | 163.8% | -7.7% | ||
| Q1 25 | 3.7% | -12.7% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | — | -6.5% | ||
| Q2 24 | 8.4% | -8.5% | ||
| Q1 24 | — | -12.3% |
| Q4 25 | $0.00 | $-0.22 | ||
| Q3 25 | — | $-0.20 | ||
| Q2 25 | $0.52 | $-0.23 | ||
| Q1 25 | $0.01 | $-0.29 | ||
| Q4 24 | — | $-0.26 | ||
| Q3 24 | — | $-0.16 | ||
| Q2 24 | $0.03 | $-0.20 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $49.9M |
| Total DebtLower is stronger | $93.2M | $444.1M |
| Stockholders' EquityBook value | $1.2B | $-1.9M |
| Total Assets | $1.8B | $1.2B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $49.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | $1.4B | $44.0M | ||
| Q1 25 | $836.1M | $33.1M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $22.4M | ||
| Q2 24 | $802.5M | $24.3M | ||
| Q1 24 | — | $12.6M |
| Q4 25 | $93.2M | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $-1.9M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $1.2B | $18.2M | ||
| Q1 25 | $759.9M | $71.4M | ||
| Q4 24 | — | $97.5M | ||
| Q3 24 | — | $110.3M | ||
| Q2 24 | $740.1M | $81.5M | ||
| Q1 24 | — | $91.7M |
| Q4 25 | $1.8B | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | — | $983.3M |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $36.7M |
| Free Cash FlowOCF − Capex | $3.4M | $27.8M |
| FCF MarginFCF / Revenue | 1.2% | 8.2% |
| Capex IntensityCapex / Revenue | 1.8% | 2.6% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $36.7M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | $-72.9M | $-7.0M | ||
| Q1 25 | $40.3M | $-22.1M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $-332.0K | ||
| Q2 24 | $-39.8M | $-23.7M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $3.4M | $27.8M | ||
| Q3 25 | — | $-44.7M | ||
| Q2 25 | $-82.2M | $-27.5M | ||
| Q1 25 | $32.5M | $-63.4M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | — | $-36.7M | ||
| Q2 24 | $-49.9M | $-59.9M | ||
| Q1 24 | — | $-60.9M |
| Q4 25 | 1.2% | 8.2% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | -29.6% | -9.8% | ||
| Q1 25 | 10.0% | -29.7% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | — | -16.6% | ||
| Q2 24 | -16.3% | -28.7% | ||
| Q1 24 | — | -31.7% |
| Q4 25 | 1.8% | 2.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 3.3% | 7.3% | ||
| Q1 25 | 2.4% | 19.3% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | 3.3% | 17.4% | ||
| Q1 24 | — | 35.8% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
